Q2 2020 Holdings
Filed 2020-08-13 | 79 holdings | $42.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $7.4M | 75,000 | 17.4% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $7.0M | 40,000 | 16.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.3M | 35,863 | 12.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.3M | 900,608 | 10.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.0M | 160,000 | 9.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $3.3M | 40,000 | 7.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.8M | 1,697,357 | 6.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.5M | 75,215 | 5.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $2.1M | 130,288 | 5.0% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $2.0M | 426,599 | 4.7% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $942.0K | 25,000 | 2.2% |
| Apyx MED Corp(APYX) | COM | 03837C106 | $391.0K | 70,497 | 0.9% |
| Clearpoint Neuro Inc(CLPT) | COM | 18507C103 | $89.0K | 25,078 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $14.8K | 121,526 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $14.7K | 119,778 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $14.6K | 261,906 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $13.2K | 32,560 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $11.8K | 800,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $11.6K | 30,000 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $9.7K | 125,826 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $8.8K | 50,000 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $8.5K | 241,909 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $8.4K | 28,500 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $8.4K | 75,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $8.3K | 120,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $7.6K | 300,805 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $7.5K | 150,133 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.4K | 590,267 | 0.0% |
| Icad Inc(ICADUSD) | COM NEW | 44934S206 | $7.2K | 725,590 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $7.1K | 110,318 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $7.0K | 95,000 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $6.7K | 47,500 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $6.6K | 475,296 | 0.0% |
| Repro MED SYS Inc(KRMD) | COM | 759910102 | $6.5K | 721,985 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $6.4K | 37,500 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.9K | 250,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $5.8K | 20,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $5.7K | 50,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $5.5K | 57,500 | 0.0% |
| Itamar MED LTD | SPONSORED ADS | 465437101 | $5.2K | 280,650 | 0.0% |
| Silk RD MED Inc | COM | 82710M100 | $5.0K | 120,000 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $4.7K | 342,875 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $3.7K | 725,000 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $3.5K | 65,218 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.4K | 17,500 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $3.3K | 40,000 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $3.3K | 190,593 | 0.0% |
| Nuance Communications Inc | COM | 67020Y100 | $3.2K | 125,056 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.0K | 125,125 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $3.0K | 668,693 | 0.0% |